Skip to main navigation Skip to search Skip to main content

A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities

  • Alexey V. Danilov
  • , Lionel D. Lewis
  • , Frederick Lansigan
  • , Liya Roudaia
  • , Darcie L. Findley
  • , Susan Y. Jones
  • , Brian Highhouse
  • , Bernard B. Beaulieu
  • , Jennifer R. Brown

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)820-823
Number of pages4
JournalBritish Journal of Haematology
Volume178
Issue number5
DOIs
StatePublished - Sep 1 2017

Funding

FundersFunder number
National Institute of Health-National Cancer InstituteP30CA023108

    Keywords

    • bendamustine
    • chronic lymphocytic leukaemia
    • comorbidities

    ASJC Scopus subject areas

    • Hematology

    Cite this